M. Michaelis, “Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 (Vemurafenib) and its Progenitor PLX4720 on ABCB1 Function”, J Pharm Pharm Sci, vol. 17, no. 1, pp. 154–168, Apr. 2014.